Lyxor Core EURO STOXX 50 (DR) - UCITS ETF Acc: Net Asset Value(s)
DJ Lyxor Core EURO STOXX 50 (DR) - UCITS ETF Acc: Net Asset Value(s)
Lyxor Core EURO STOXX 50 (DR) - UCITS ETF Acc (MSED LN)
Lyxor Core EURO STOXX 50 (DR) - UCITS ETF Acc: Net Asset Value(s)
20-Apr-2021 / 09:22 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
= -
Net Asset Value(s)
FUND: Lyxor Core EURO STOXX 50 (DR) - UCITS ETF Acc
DEALING DATE: 19-Apr-2021
NAV PER SHARE: EUR: 200.0949
NUMBER OF SHARES IN ISSUE: 449759
Lyxor Core EURO STOXX 300 (DR) - UCITS ETF Dist: Net Asset Value(s)
DJ Lyxor Core EURO STOXX 300 (DR) - UCITS ETF Dist: Net Asset Value(s)
Lyxor Core EURO STOXX 300 (DR) - UCITS ETF Dist (MFDD LN)
Lyxor Core EURO STOXX 300 (DR) - UCITS ETF Dist: Net Asset Value(s)
20-Apr-2021 / 09:22 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
= -
Net Asset Value(s)
FUND: Lyxor Core EURO STOXX 300 (DR) - UCITS ETF Dist
DEALING DATE: 19-Apr-2021
NAV PER SHARE: EUR: 167.1204
NUMBER OF SHARES IN ISSUE: 77737
(0)
NEW YORK, April 20, 2021 /PRNewswire/
Prevalence of skin diseases is constantly on the rise, globally. This is constructing major health encumbrance on most economies. A healthcare facility that is supervised by a licensed healthcare provider, full time, is termed as a medical spa. The objective of the industry is to offer medical education and care in a setting that includes spa facilities as well as conventional, complementary, and/or alternative therapies and treatments. Botox injections, anti-wrinkle and fine line reduction therapies, acne surgery, and fillers are some of the latest laser procedures offered at medical spas. Facials and massages are provided at conventional spas, but in medical spas, these treatments are performed with highly specialized lasers and instruments to permit for larger penetration of medical-grade skin items.
Procter & Gamble Maintains 2021 Outlook; To Pay More Than $8 Bln In Dividends
CINCINNATI (dpa-AFX) - The Procter & Gamble Company (PG) said it continues to expect fiscal 2021 GAAP net
earnings per share growth in the range of eight to ten percent from fiscal 2020 GAAP EPS of $4.96. It maintained guidance for core earnings per share growth in the range of eight to ten percent. The company maintained its outlook for fiscal 2021 all-in and organic sales growth in the range of five to six percent.
The Procter & Gamble Company expects to pay more than $8 billion in dividends in fiscal 2021. The company increased its outlook for stock repurchase from up to $10 billion to approximately $11 billion. Combined, the company now plans to return about $19 billion of cash to shareowners in fiscal 2021.
Vancouver, British Columbia (Newsfile Corp. - April 20, 2021) - Quaterra Resources Inc. (OTCQB: QTRRF) (TSXV: QTA) ("Quaterra" or the "Company") today announced that a 7,000 -10,000-foot core drilling